Literature DB >> 27190887

Treatment of Resıstant Cyclophosphamide Induced Haemorrhagic Cystıtıs: Revıew of Literature and Three Case Reports.

Turgay Ebiloglu1, Engin Kaya2, Sercan Yilmaz2, Gökhan Özgür3, Yusuf Kibar2.   

Abstract

Haemorrhagic Cystitis (HC) is defined as diffuse inflammatory bladder bleeding due to many aetiologies. Massive HC often arises from anticancer chemotherapy or radiotherapy for the treatment of pelvic malignancies. Phosphamides are the anti-cancer drugs used for treating breast cancer, B-cell lymphoma, leukemia, rheumatoid arthritis and systemic lupus erythaematosis by cross-linking strands of DNA and preventing the cell division. They are also used in bone marrow transplantation for prevention of Graft Versus Host Disease (GVHD). Hepatic metabolism of phosphamide forms acrolein, and acrolein makes ulceration, haemorrhage, edema and necrosis of the urothelium during its excretion by the urine. Infectious causes of HC in immunocomprimesed patients are adenovirus, BK polyoma-virus (BK), JC virus, and Cytomegalovirus (CMV). The present article attempts to make a review of literature for the treatment of intractable HC and report three cases with HC.

Entities:  

Keywords:  Cidofoxin therapy; Clot; Haematuria

Year:  2016        PMID: 27190887      PMCID: PMC4866185          DOI: 10.7860/JCDR/2016/16948.7642

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  14 in total

1.  Intractable hemorrhagic cystitis after hematopoietic stem cell tranplantation--is there a role for early urinary diversion in children?

Authors:  Stephen J Lukasewycz; Angela R Smith; Aksharananda Rambachan; Margaret L MacMillan; Jane M Lewis; Aseem R Shukla
Journal:  J Urol       Date:  2012-05-15       Impact factor: 7.450

2.  Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy.

Authors:  A A Ashrani; D A Gabriel; J L Gajewski; D R Jacobs; D J Weisdorf; N S Key
Journal:  Bone Marrow Transplant       Date:  2006-12       Impact factor: 5.483

3.  Effect of serum urokinase on urine fibrinolytic activity.

Authors:  S Y Hong; S J Pyo; H B Lee
Journal:  Nephron       Date:  1990       Impact factor: 2.847

4.  Treatment of radiation-induced hemorrhagic cystitis with laparoscopic cystoprostatectomy.

Authors:  Ilter Alkan; Stephan Jeschke; Karl Leeb; Nasser Albquami; Gunter Janetschek
Journal:  Urol Int       Date:  2006       Impact factor: 2.089

Review 5.  Leflunomide in clinical practice.

Authors:  Patrícia Pinto; Maxime Dougados
Journal:  Acta Reumatol Port       Date:  2006 Jul-Sep       Impact factor: 1.290

6.  Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen: long-term followup.

Authors:  J J Del Pizzo; B H Chew; S C Jacobs; G N Sklar
Journal:  J Urol       Date:  1998-09       Impact factor: 7.450

7.  Efficacy and safety of leflunomide for the treatment of BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients.

Authors:  Xin-Chuan Chen; Ting Liu; Jian-Jun Li; Chuan He; Weng-Tong Meng; Rui Huang
Journal:  Acta Haematol       Date:  2013-02-14       Impact factor: 2.195

8.  Hemorrhagic cystitis: A challenge to the urologist.

Authors:  R Manikandan; Santosh Kumar; Lalgudi N Dorairajan
Journal:  Indian J Urol       Date:  2010-04

9.  When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?

Authors:  M Dougados; P Emery; E M Lemmel; C A F Zerbini; S Brin; P van Riel
Journal:  Ann Rheum Dis       Date:  2004-07-22       Impact factor: 19.103

10.  Comparision of uroprotective activity of reduced glutathione with mesna in ifosfamide induced hemorrhagic cystitis in rats.

Authors:  Syed Amir Ali; Sandeep Kumar Danda; Syed Abdul Azeez Basha; Asif Rasheed; Osman Ahmed; M Muqtedar Ahmed
Journal:  Indian J Pharmacol       Date:  2014 Jan-Feb       Impact factor: 1.200

View more
  1 in total

1.  Rho kinase inhibition ameliorates cyclophosphamide-induced cystitis in rats.

Authors:  Andrzej Wróbel; Urszula Doboszewska; Ewa Rechberger; Karol Rojek; Anna Serefko; Ewa Poleszak; Krystyna Skalicka-Woźniak; Jarosław Dudka; Piotr Wlaź
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-21       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.